Literature DB >> 7019341

A rapid immunoperoxidase assay for determination of IgG antibodies to measles virus.

L Shani, H Haikin, I Sarov.   

Abstract

A new indirect peroxidase antibody to membrane antigen (IPAMA) technique for the detection of IgG specific antibodies against measles virus is described. The technique utilizes as antigen measles-infected Vero cells dried on glass slides and stored at --70 degrees C. Sera of 509 healthy medical students and laboratory workers and 24 sera of measles, encephalitis, and subacute sclerosing panencephalitis (SSPE) patients were checked by IPAMA and the results have been compared with the results obtained by the hemagglutination-inhibition (HI) test. There is good agreement between the results of both techniques as to the presence or absence of antibody in 48 out of the 50 tested. The advantages of the techniques are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019341     DOI: 10.1016/0022-1759(81)90367-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Virus-specific IgA in serum, saliva, and tears of children with measles.

Authors:  M G Friedman; M Phillip; R Dagan
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses.

Authors:  N E Cremer; C K Cossen; G Shell; J Diggs; D Gallo; N J Schmidt
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

3.  Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).

Authors:  R Shainkin-Kestenbaum; S Zimlichman; Y Winikoff; M Pras; C Chaimovitz; I Sarov
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

4.  Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19.

Authors:  Luciana Regina Meireles; Angélica Moura Freixeira da Silva; Camila Aparecida Carvalho; Norival Kesper; Andrés Jimenez Galisteo; Camila Pereira Soares; Danielle Bastos Araujo; Edison Luiz Durigon; Danielle Bruna Leal Oliveira; Lígia Morganti; Rosa Maria Chura-Chambi; Heitor Franco de Andrade
Journal:  Clinics (Sao Paulo)       Date:  2020-12-09       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.